{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:31:07Z","timestamp":1782160267682,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jgar.2025.11.011","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:22:40Z","timestamp":1763648560000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prevalence of pretreatment HIV-1 resistance to integrase strand transfer inhibitors in newly diagnosed and antiretroviral therapy-naive adults in Benin, West Africa"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-2105","authenticated-orcid":false,"given":"Edmond","family":"Tchiakpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene K.","family":"Keke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-6245","authenticated-orcid":false,"given":"Abou Abdallah Malick","family":"Diouara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halimatou","family":"Diop-Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coumba","family":"Toure-Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akadiri","family":"Yessoufou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.11.011_bib0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s13104-018-3492-5","article-title":"Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco","volume":"11","author":"Alaoui","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jgar.2025.11.011_bib0002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13104-020-05151-w","article-title":"Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin","volume":"13","author":"Tchiakpe","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jgar.2025.11.011_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi","year":"2023","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jgar.2025.11.011_bib0004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s13104-018-3804-9","article-title":"Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea","volume":"11","author":"Mbange","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jgar.2025.11.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/11786337211014503","article-title":"High HIV-1 virological failure and drug resistance among adult patients receiving first-line ART for At least 12\u2009months at a decentralized urban HIV clinic setting in Senegal before the test-and-treat","volume":"14","author":"Ekollo Mbange","year":"2021","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.jgar.2025.11.011_bib0006","unstructured":"UNAIDS. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2022_en.pdf. Accessed on 06\/12\/2025."},{"key":"10.1016\/j.jgar.2025.11.011_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1139\/cjm-2015-0725","article-title":"Might dolutegravir be part of a functional cure for HIV?","volume":"62","author":"Wainberg","year":"2016","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.jgar.2025.11.011_bib0008","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2025.11.011_bib0009","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/v15020546","article-title":"Prevalence of HIV-1 natural polymorphisms and integrase-resistance-associated mutations in African children","volume":"15","author":"Fofana","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2025.11.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30252-6","article-title":"Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey","volume":"7","author":"Hemelaar","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jgar.2025.11.011_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1510916","article-title":"Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018\u20132022","volume":"15","author":"Lu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2025.11.011_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66905-1","article-title":"HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-na\u00efve adult patients in Luanda, Angola","volume":"14","author":"Sebasti\u00e3o","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2025.11.011_bib0013","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jac\/dky005","article-title":"Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa","volume":"73","author":"Inzaule","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.11.011_bib0014","unstructured":"National AIDS Control Program (PNLS). Policy, Standards and Procedures for the Care of People Living with HIV in Benin. MedboxOrg. PNLS. https:\/\/www.medbox.org\/pdf\/5e148832db60a2044c2d60b8. 2012. Accessed on 06\/12\/2025"},{"key":"10.1016\/j.jgar.2025.11.011_bib0015","unstructured":"National AIDS Control Program (PNLS). Policy, standards and procedures for the care of people living with HIV in Benin. 2019. Accessed on 06\/12\/2025"},{"key":"10.1016\/j.jgar.2025.11.011_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JVI.01534-07","article-title":"Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303\/GS-9137)","volume":"82","author":"Shimura","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2025.11.011_bib0017","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/AAC.01228-07","article-title":"Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro","volume":"52","author":"Malet","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.11.011_bib0018","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/v15071458","article-title":"Pre-treatment HIV drug resistance and genetic diversity in Cameroon: implications for first-line regimens","volume":"15","author":"Fokam","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2025.11.011_bib0019","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/aid.2011.0326","article-title":"Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations","volume":"28","author":"Monleau","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2025.11.011_bib0020","doi-asserted-by":"crossref","first-page":"1051096","DOI":"10.3389\/fmicb.2022.1051096","article-title":"Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens","volume":"13","author":"Gil","year":"2022","journal-title":"Front Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652500253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652500253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:50:01Z","timestamp":1781509801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652500253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"alternative-id":["S221371652500253X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.11.011","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of pretreatment HIV-1 resistance to integrase strand transfer inhibitors in newly diagnosed and antiretroviral therapy-naive adults in Benin, West Africa","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}